BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25749987)

  • 1. A correlation between decreased parathyroid α-Klotho and fibroblast growth factor receptor 1 expression with pathological category and parathyroid gland volume in dialysis patients.
    Yan J; Jingbo C; Wang D; Xie S; Yuan L; Zhong X; Hao L
    Int Urol Nephrol; 2015 Apr; 47(4):701-6. PubMed ID: 25749987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.
    Kumata C; Mizobuchi M; Ogata H; Koiwa F; Nakazawa A; Kondo F; Kadokura Y; Kinugasa E; Akizawa T
    Am J Nephrol; 2010; 31(3):230-8. PubMed ID: 20068287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.
    Latus J; Lehmann R; Roesel M; Fritz P; Braun N; Ulmer C; Steurer W; Biegger D; Ott G; Dippon J; Alscher MD; Kimmel M
    Kidney Blood Press Res; 2013; 37(1):84-94. PubMed ID: 23552627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.
    Komaba H; Goto S; Fujii H; Hamada Y; Kobayashi A; Shibuya K; Tominaga Y; Otsuki N; Nibu K; Nakagawa K; Tsugawa N; Okano T; Kitazawa R; Fukagawa M; Kita T
    Kidney Int; 2010 Feb; 77(3):232-8. PubMed ID: 19890272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
    Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
    Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism.
    Albuquerque RFC; Carbonara CEM; Martin RCT; Dos Reis LM; do Nascimento CP; Arap SS; Moysés RMA; Jorgetti V; Montenegro FLM; de Oliveira RB
    Surgery; 2018 Feb; 163(2):381-387. PubMed ID: 29146232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased parathyroid Klotho expression is associated with persistent hyperparathyroidism after kidney transplantation.
    Hong YA; Choi DE; Lim SW; Yang CW; Chang YK
    Transplant Proc; 2013 Oct; 45(8):2957-62. PubMed ID: 24157012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
    Tokumoto M; Tsuruya K; Fukuda K; Kanai H; Kuroki S; Hirakata H
    Kidney Int; 2002 Oct; 62(4):1196-207. PubMed ID: 12234290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the dimension of parathyroid glands estimated by ultrasonography and the hyperplastic pattern in patients with renal hyperparathyroidism.
    Matsuoka S; Tominaga Y; Sato T; Uno N; Hiramitu T; Goto N; Nagasaka T; Uchida K
    Ther Apher Dial; 2008 Oct; 12(5):391-5. PubMed ID: 18937723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased parathyroid expression of klotho in uremic rats.
    Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
    Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients?
    Lafage-Proust MH
    Kidney Int; 2010 Mar; 77(5):390-2. PubMed ID: 20150940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent alpha-Klotho (a-Kl) expression in the parathyroid glands of patients with secondary hyperparathyroidism.
    Ohkido I; Yokoyama K; Imura A; Utsunomiya Y; Hosoya T; Nabeshima Y
    Nephrol Dial Transplant; 2010 Mar; 25(3):1007-8; author reply 1008-9. PubMed ID: 20075437
    [No Abstract]   [Full Text] [Related]  

  • 13. [Optical and ultrastructural morphology in hyperparathyroidism during dialysis].
    Schiaffino E; Zogno C; Schmid C; Mangili F; Cantaboni A
    Pathologica; 1992; 84(1092):445-58. PubMed ID: 1491886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy.
    Tominaga Y; Matsuoka S; Sato T; Uno N; Goto N; Katayama A; Haba T;
    Ther Apher Dial; 2007 Aug; 11(4):266-73. PubMed ID: 17661832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic Features of Parathyroid Glands Associated With the Pathogenesis of Long-lasting Persistent Hyperparathyroidism After Kidney Transplantation in Long-term Dialysis Patients.
    Nakamura M; Ishida H; Takiguchi S; Tanaka K; Marui Y
    Transplant Proc; 2016 Apr; 48(3):874-7. PubMed ID: 27234756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats.
    Ritter CS; Zhang S; Delmez J; Finch JL; Slatopolsky E
    Kidney Int; 2015 Jun; 87(6):1141-52. PubMed ID: 25692955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinacalcet upregulates calcium-sensing receptors of parathyroid glands in hemodialysis patients.
    Sumida K; Nakamura M; Ubara Y; Marui Y; Tanaka K; Takaichi K; Tomikawa S; Inoshita N; Ohashi K
    Am J Nephrol; 2013; 37(5):405-12. PubMed ID: 23594726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid pathology in hyperparathyroidism secondary to chronic renal failure.
    Malmaeus J; Grimelius L; Johansson H; Akerström G; Ljunghall S
    Scand J Urol Nephrol; 1984; 18(2):157-66. PubMed ID: 6379860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism.
    Koiwa F; Kakuta T; Tanaka R; Yumita S
    Nephrol Dial Transplant; 2007 Feb; 22(2):522-8. PubMed ID: 17127701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological alterations of the parathyroid glands in haemodialysis patients with secondary hyperparathyroidism refractory to cinacalcet hydrochloride.
    Sumida K; Nakamura M; Ubara Y; Marui Y; Tanaka K; Takaichi K; Tomikawa S; Inoshita N; Ohashi K
    J Clin Pathol; 2011 Sep; 64(9):756-60. PubMed ID: 21565858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.